866-997-4948(US-Canada Toll Free)

Porcine Vaccines Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Apr 2018

Category :

Vaccines

No. of Pages : 240 Pages

Porcine Vaccines Market - Overview

This report on the porcine vaccines market analyzes the current and future scenario of the global market. Increase in the prevalence of diseases among swine, technological advancements of RNA strand methodology, and cultivation of pigs to raise standards of living are likely to drive the global porcine vaccines market during the forecast period. Increase in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the factors expected to drive the global porcine vaccines market during the forecast period.

This report on the global porcine vaccines market comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the market with respect to segments based on disease indication, technology, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porter’s five forces analysis to help understand the competition landscape of the market. This section also provides market attractiveness analysis, in terms of country, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competition scenario in the global porcine vaccines market.

Based on technology, the porcine vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. These market segments have been extensively analyzed based on increase in the demand for treatment of diseases such as PED, PRRS, and PCVAD. Surging demand for disease-free pork meat and increasing awareness for treating cultivated pigs are driving the technology segments of the market. Different types of end-users utilize porcine vaccines to treat swine diseases. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospitals segment. The market size (in terms of US$ Mn) and forecast for each segment have been provided for the period from 2015 to 2025. The report also provides the compounded annual growth rate (CAGR %) for each segment for the period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others. Diarrhoea is the most widespread disease among pigs across the world. Porcine epidemic diarrhea virus (PEDV) hit the U.S. in 2013 and spread to Canada in 2014, which infected piglets. It had 80%–100% mortality rate. The above-mentioned segments have been analyzed based on available approved products, their cost-effectiveness, and preference by veterinarians for treating swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global porcine vaccines market has been categorized into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in the market in these regions.

The report also profiles major players in the global porcine vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report are Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Vetoquinol, and Zoetis Inc.

The global porcine vaccines market has been segmented as below:

Global Porcine Vaccines Market, by Disease Indication, 2015–2025

  • Diarrhea
  • Swine Influenza
  • Arthritis
  • Bordetella Rhinitis
  • Porcine Reproductive and Respiratory Syndrome (PRRS)
  • Porcine Circovirus Associated Disease (PCVAD)
  • Others (CHRS, Leptospirosis, etc.)

Global Porcine Vaccines Market, by Technology, 2015–2025

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
  • DNA Vaccines

Global Porcine Vaccines Market, by End-user, 2015–2025

  • Veterinary Hospitals
  • Hog Production Farms

Global Porcine Vaccines Market, by Geography, 2015–2025

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Table of Content

Chapter 1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2.Assumptions and Research Methodology

Chapter 3.Executive Summary : Global Porcine Vaccines Market

Chapter 4.Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Market Evolution / Developments
4.2.  Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Porcine Vaccines Market Analysis and Forecast, 2015–2025
4.4.1. Market Revenue Projection (US$ Mn)
4.5. Porter’s Five Forces Analysis
4.6. Market Outlook
4.7.Regulatory Scenario Assessment
4.7.1. North America
4.7.2. Europe
4.7.3. Asia Pacific
4.8.Disease Indication Comparison, by Region
4.8.1. North America
4.8.2. Europe 
4.8.3. Asia Pacific
4.8.4. Latin America
4.8.5. Middle East & Africa
4.9.Swine Production Level, by Region/State
4.9.1. North America
4.9.2. Europe 
4.9.3. Asia Pacific
4.9.4. Latin America
4.10.Product Launches and Innovations
4.11. Recent Market Activities
4.12.Introduction of New Types of Vaccines
4.13. Snapshot of Market Trends and Issues

Chapter 5.Global Porcine Vaccines Market Analysis and Forecast, by End-user   
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast by End-user, 2015–2025
5.3.1. Inactivated Vaccines
5.3.2. Live Attenuated Vaccines
5.3.3. Toxoid Vaccines
5.3.4. Recombinant Vaccines
5.3.5. Conjugate Vaccines
5.3.6. DNA Vaccines
5.4. Market Attractiveness, by End-user   

Chapter 6.Global Porcine Vaccines Market Analysis and Forecast, by Disease Indication 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Disease Indication, 2015–2025
6.3.1. Diarrhea 
6.3.2. Swine Influenza 
6.3.3. Arthritis
6.3.4. Bordetella Rhinitis 
6.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
6.3.6. Porcine Circovirus Associated Disease (PCVAD)
6.3.7. Others
6.4. Market Attractiveness, by Disease Indication 

Chapter 7.Global Porcine Vaccines Market Analysis and Forecast, by End-user   
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2015–2025
7.3.1. Veterinary Hospitals
7.3.2. Hog Production Farms
7.4. Market Attractiveness, by End-user   

Chapter 8.Global Porcine Vaccines Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America 
8.2.2. Europe 
8.2.3. Asia Pacific 
8.2.4. Latin America 
8.2.5. Middle East & Africa 
8.3. Market Attractiveness, by Country/Region 

Chapter 9.North America Porcine Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by End-user, 2015–2025
9.2.1. Inactivated Vaccines
9.2.2. Live Attenuated Vaccines
9.2.3. Toxoid Vaccines
9.2.4. Recombinant Vaccines
9.2.5. Conjugate Vaccines
9.2.6. DNA Vaccines
9.3. Market Value Forecast, by Disease Indication, 2015–2025
9.3.1. Diarrhea 
9.3.2. Swine Influenza 
9.3.3. Arthritis
9.3.4. Bordetella Rhinitis 
9.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
9.3.6. Porcine Circovirus Associated Disease (PCVAD)
9.3.7. Others
9.4. Market Value Forecast, by End-user, 2015–2025
9.4.1. Veterinary Hospitals
9.4.2. Hog Production Farms
9.5. Market Value Forecast, by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis 
9.6.1. By End-user   
9.6.2. By Disease Indication 
9.6.3. By End-user   
9.6.4. By Country

Chapter 10.Europe Porcine Vaccines Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast, by End-user, 2015–2025
10.2.1. Inactivated Vaccines
10.2.2. Live Attenuated Vaccines
10.2.3. Toxoid Vaccines
10.2.4. Recombinant Vaccines
10.2.5. Conjugate Vaccines
10.2.6. DNA Vaccines
10.3.Market Value Forecast, by Disease Indication, 2015–2025
10.3.1. Diarrhea 
10.3.2. Swine Influenza 
10.3.3. Arthritis
10.3.4. Bordetella Rhinitis 
10.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
10.3.6. Porcine Circovirus Associated Disease (PCVAD)
10.3.7. Others
10.4.Market Value Forecast, by End-user, 2015–2025
10.4.1. Veterinary Hospitals
10.4.2. Hog Production Farms
10.5.Market Value Forecast, by Country/Sub-region, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Russia
10.5.7. Rest of Europe
10.6.Market Attractiveness Analysis 
10.6.1. By End-user   
10.6.2. By Disease Indication 
10.6.3. By End-user   
10.6.4. By Country/Sub-region

Chapter 11.Asia Pacific Porcine Vaccines Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by End-user, 2015–2025
11.2.1. Inactivated Vaccines
11.2.2. Live Attenuated Vaccines
11.2.3. Toxoid Vaccines
11.2.4. Recombinant Vaccines
11.2.5. Conjugate Vaccines
11.2.6. DNA Vaccines
11.3.Market Value Forecast, by Disease Indication, 2015–2025
11.3.1. Diarrhea 
11.3.2. Swine Influenza 
11.3.3. Arthritis
11.3.4. Bordetella Rhinitis 
11.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
11.3.6. Porcine Circovirus Associated Disease (PCVAD)
11.3.7. Others
11.4.Market Value Forecast, by End-user, 2015–2025
11.4.1. Veterinary Hospitals
11.4.2. Hog Production Farms
11.5.Market Value Forecast, by Country/Sub-region, 2015–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6.Market Attractiveness Analysis 
11.6.1. By End-user   
11.6.2. By Disease Indication
11.6.3. By End-user   
11.6.4. By Country/Sub-region

Chapter 12.Latin America Porcine Vaccines Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by End-user, 2015–2025
12.2.1. Inactivated Vaccines
12.2.2. Live Attenuated Vaccines
12.2.3. Toxoid Vaccines
12.2.4. Recombinant Vaccines
12.2.5. Conjugate Vaccines
12.2.6. DNA Vaccines
12.3.Market Value Forecast, by Disease Indication, 2015–2025
12.3.1. Diarrhea 
12.3.2. Swine Influenza 
12.3.3. Arthritis
12.3.4. Bordetella Rhinitis 
12.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
12.3.6. Porcine Circovirus Associated Disease (PCVAD)
12.3.7. Others
12.4.Market Value Forecast, by End-user, 2015–2025
12.4.1. Veterinary Hospitals
12.4.2. Hog Production Farms
12.5.Market Value Forecast, by Country/Sub-region, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6.Market Attractiveness Analysis 
12.6.1. By End-user   
12.6.2. By Disease Indication 
12.6.3. By End-user   
12.6.4. By Country/Sub-region

Chapter 13.Middle East & Africa Porcine Vaccines Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by End-user, 2015–2025
13.2.1. Inactivated Vaccines
13.2.2. Live Attenuated Vaccines
13.2.3. Toxoid Vaccines
13.2.4. Recombinant Vaccines
13.2.5. Conjugate Vaccines
13.2.6. DNA Vaccines
13.3.Market Value Forecast, by Disease Indication, 2015–2025
13.3.1. Diarrhea 
13.3.2. Swine Influenza 
13.3.3. Arthritis
13.3.4. Bordetella Rhinitis 
13.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
13.3.6. Porcine Circovirus Associated Disease (PCVAD)
13.3.7. Others
13.4.Market Value Forecast, by End-user, 2015–2025
13.4.1. Veterinary Hospitals
13.4.2. Hog Production Farms
13.5.Market Value Forecast, by Country/Sub-region, 2015–2025
13.5.1. South Africa
13.5.2. Rest of Middle East & Africa
13.6.Market Attractiveness Analysis 
13.6.1. By End-user   
13.6.2. By Disease Indication 
13.6.3. By End-user   
13.6.4. By Country/Sub-region

Chapter 14.Competition Landscape
14.1.Market Player – Competition Matrix (by Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
14.2.1. Bayer AG
14.2.1.1. Overview
14.2.1.2. Financials
14.2.1.3. Recent Developments
14.2.1.4. Strategy
14.2.2. Bimeda Animal Health 
14.2.2.1. Overview
14.2.2.2. Financials
14.2.2.3. Recent Developments
14.2.2.4. Strategy
14.2.2. Boehringer Ingelheim GmbH 
14.2.3.1. Overview
14.2.3.2. Financials
14.2.3.3. Recent Developments
14.2.3.4. Strategy
14.2.4. Ceva Santé Animale
14.2.4.1. Overview
14.2.4.2. Financials
14.2.4.3. Recent Developments
14.2.4.4. Strategy 
14.2.5. Elanco (Eli Lilly and Company)
14.2.5.1. Overview
14.2.5.2. Financials
14.2.5.3. Recent Developments
14.2.5.4. Strategy
14.2.6. Merck & Co., Inc.
14.2.6.1. Overview
14.2.6.2. Financials
14.2.6.3. Recent Developments
14.2.6.4. Strategy 
14.2.7. Vetoquinol
14.2.7.1. Overview
14.2.7.2. Financials
14.2.7.3. Recent Developments
14.2.7.4. Strategy
14.2.8. Zoetis, Inc.
14.2.8.1. Overview
14.2.8.2. Financials
14.2.8.3. Recent Developments
14.2.8.4. Strategy
14.2.9. Others

List of Table

Table 01: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 02: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 03: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 07: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 08: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 11: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 12: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 15: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 16: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 19: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 20: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 23: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 24: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Chart

FIG 01: Global Porcine Vaccines Market Size (US$ Mn) Forecast, 2015–2025
FIG 02: Global Porcine Vaccines Market Value Share, by Technology (2016)
FIG 03: Global Porcine Vaccines Market Value Share, by Region (2016)
FIG 04: Global Porcine Vaccines Market Value Share, by End-user (2016)
FIG 05: Global Porcine Vaccines Market Value Share, by Disease Indication (2016)
FIG 06: Global Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 07: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inactivated Vaccines, 2015–2025
FIG 08: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Live Attenuated Vaccines, 2015–2025
FIG 09: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Toxoid Vaccines, 2015–2025
FIG 10: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Recombinant Vaccines, 2015–2025
FIG 11: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Conjugate Vaccines, 2015–2025
FIG 12: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by DNA Vaccines, 2015–2025
FIG 13: Global Porcine Vaccines Market Attractiveness, by Technology, 2017–2025
FIG 14: Global Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 15: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diarrhea, 2015–2025
FIG 16: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Swine Influenza, 2015–2025
FIG 17: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Arthritis, 2015–2025
FIG 18: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bordetella Rhinitis, 2015–2025
FIG 19: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PRRS, 2015–2025
FIG 20: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCVAD, 2015–2025
FIG 21: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
FIG 22: Global Porcine Vaccines Market Attractiveness, by Disease Indication, 2017–2025
FIG 23: Global Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 24: Global Porcine Vaccines Market Attractiveness, by End-user, 2017–2025
FIG 25: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Veterinary Hospitals, 2015–2025
FIG 26: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hog Production Farms, 2015–2025
FIG 27: Global Porcine Vaccines Market Value Share, by Region, 2017 and 2025 
FIG 28: Global Porcine Vaccines Market Attractiveness, by Region, 2017–2025
FIG 29: North America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 30: North America Porcine Vaccines Market Attractiveness, by Country, 2017–2025
FIG 31: North America Porcine Vaccines Market Value Share Analysis, by Country, 2017 and 2025
FIG 32: North America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 33: North America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 34: North America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 35: North America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 36: North America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 37: North America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 38: North America Swine Production Level, by Top Countries/States
FIG 39: Europe Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 40: Europe Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 41: Europe Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 41: Europe Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 43: Europe Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 44: Europe Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 45: Europe Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 46: Europe Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 47: Europe Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 48: Europe Swine Production Level, by Top Countries/States
FIG 49: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 50: Asia Pacific Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 51: Asia Pacific Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 52: Asia Pacific Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 53: Asia Pacific Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 54: Asia Pacific Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 55: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 56: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 57: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 58: Asia Pacific Swine Production Level, by Top Countries/States
FIG 59: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 60: Latin America Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 61: Latin America Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 62: Latin America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 63: Latin America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 64: Latin America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 65: Latin America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 66: Latin America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 67: Latin America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 68: Latin America Swine Production Level, by Top Countries/States
FIG 69: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 70: Middle East & Africa Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 71: Middle East & Africa Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 72: Middle East & Africa  Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 73: Middle East & Africa  Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 74: Middle East & Africa  Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 75: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 76: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 77: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 78: Global Porcine Vaccines Market Share Analysis, by Company, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *